ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Graft-versus-myeloma effect: Proof of principle
Author(s): Tricot G, Vesole DH, Jagannath S, Hilton J, Munshi N, Barlogie B
Source: BLOOD    Volume: 87    Issue: 3    Pages: 1196-1198    Published: FEB 1 1996  
Times Cited: 295     References: 26     
Abstract: The presence of a graft-versus-tumor effect has been well established in leukemia but not in multiple myeloma. A 40-year-old patient with myeloma refractory to standard chemotherapy and autologous transplantation received matched unrelated T-cell-depleted transplant after conditioning with fractionated total-body irradiation, thiotepa, and cyclophosphamide. This procedure resulted in a transient and incomplete response with evidence of rapidly progressive disease within 2.5 months posttransplantation. The patient then received a small number of donor peripheral blood (PB) mononuclear cells (CD3 cells 1.2 x 10(6)/kg) without any further cytotoxic therapy. A complete remission was attained, lasting now for more than 14 months. The procedure was associated with severe acute and subsequently limited chronic graft-versus-host disease (GVHD). This report provides the first direct evidence of a graft-versus-myeloma effect after allogeneic transplantation. (C) 1996 by The American Society of Hematology.
Document Type: Article
Language: English
Reprint Address: Tricot, G (reprint author), UNIV ARKANSAS MED SCI HOSP, DIV HEMATOL ONCOL, 4301 W MARKHAM, SLOT 508, LITTLE ROCK, AR 72205 USA
Addresses:
1. UNIV ARKANSAS MED SCI HOSP, ARKANSAS CANC RES CTR, LITTLE ROCK, AR 72205 USA
Publisher: W B SAUNDERS CO, INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399
Subject Category: Hematology
IDS Number: TT484
ISSN: 0006-4971
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo